(Q74610152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

main subject

localized osteosarcoma

1 reference

based on heuristic

inferred from title

metastatic osteosarcoma

1 reference

6

I L Andrulis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

N Gokgoz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J S Wunder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Mousses

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Eskandarian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R S Bell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

2181-2189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Osteogenic sarcoma with clinically detectable metastasis at initial presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Synchronous multifocal osteosarcoma: results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Prognostic factors in osteosarcoma: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Colorectal Cancer and the Intersection between Basic and Clinical Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

The status of p53 in the metastatic progression of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Prognostic value of p53 genetic changes in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Gain of function mutations in p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Functional inactivation of genes by dominant negative mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Different tumor-derived p53 mutants exhibit distinct biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Alterations of the p53, Rb and MDM2 genes in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li – Fraumeni patients carrying a mutation to the TP53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Trends and variability in survival among patients with osteosarcoma: a 7-year update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

Tumor size and prognosis in aggressively treated osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

p53 mutations in primary human lung tumors and their metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

p53 mutations in matched primary and metastatic human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011015%2992%3A8%3C2181%3A%3AAID-CNCR1561%3E3.0.CO%3B2-3

10.1002/1097-0142(20011015)92:8<2181::AID-CNCR1561>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11596036%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference